CramPDF Co., ltd provides valid exam cram PDF & dumps PDF materials to help candidates pass exam certainly. If you want to get certifications in the short time please choose CramPDF exam cram or dumps PDF file.

Study HIGH Quality CCDS-O Free Study Guides and Exams Tutorials [Q57-Q82]

Share

Study HIGH Quality CCDS-O  Free Study Guides and Exams Tutorials

Download ACDIS CCDS-O Exam Dumps to Pass Exam Easily

NEW QUESTION # 57
A patient presents to the clinic for follow up of type 2 diabetes. The patient is also noted to have peripheral neuropathy. The patient has COPD and is found to have no recent exacerbations. The patient also has a history of depression, reported as stable. Which of the following CMS-HCCs will be captured for this visit?
HCC 17: Diabetes with Acute Complications
HCC 18: Diabetes with Chronic Complications
HCC 19: Diabetes without Complications
HCC 58: Major Depressive, Bipolar and Paranoid Disorders
HCC 111: Chronic Obstructive Pulmonary Disease

  • A. HCC 17 and HCC 58
  • B. HCC 19, HCC 58, and HCC 111
  • C. HCC 18 and HCC 111
  • D. HCC 18, HCC 19, and HCC 111

Answer: C

Explanation:
In the CMS-HCC model, diabetes categories are hierarchical, meaning you capture the highest supported diabetes HCC for the year, not multiple diabetes HCCs simultaneously. Type 2 diabetes with peripheral neuropathy represents a chronic diabetic complication, so it maps to HCC 18 (Diabetes with Chronic Complications) rather than HCC 19 (without complications) or HCC 17 (acute complications). COPD is documented as present and clinically relevant (even without an exacerbation) and therefore maps to HCC 111 (Chronic Obstructive Pulmonary Disease) when it is assessed/managed as part of the visit. "History of depression, stable" does not necessarily meet the threshold for HCC 58, which is reserved for specific serious psychiatric diagnoses (e.g., major depressive disorder, bipolar disorder, paranoid disorders). A general "depression" history, especially if not specified as major depressive disorder and not actively addressed, often will not support HCC 58 capture. Therefore, the visit captures HCC 18 and HCC 111 only.


NEW QUESTION # 58
A patient returns to a PCP for follow-up care related to a UTI. The provider documents "stage 3 CKD" as determined by a single eGFR of 52 mL/min. Which of the following actions should the CDI specialist take?

  • A. Delete CKD diagnosis from claim as it was not treated during this encounter.
  • B. Add diagnosis of CKD stage 3 to claim, as it is reportable.
  • C. Review CKD staging criteria with provider.
  • D. Query for stage 4 CKD.

Answer: C

Explanation:
The CDI specialist should review CKD staging criteria with the provider because assigning CKD based on a single eGFR value can be clinically unreliable and may lead to inaccurate documentation and coding. Outpatient CDI guidance emphasizes that documentation must reflect a condition that is clinically valid, supported by the record, and accurately described, especially for chronic diseases. CKD is generally established by evidence of decreased kidney function or kidney damage that is persistent, not a one-time lab that could be affected by hydration status, acute illness, medications, or transient physiologic changes. While an eGFR of 52 falls within the numeric range commonly associated with stage 3a, the key CDI issue is the foundation for diagnosing chronic disease, not simply whether the number is "reportable." Option A inappropriately directs CDI to add diagnoses to claims; CDI supports providers and coding, but does not independently "add" conditions. Option C is incorrect because chronic conditions may be coded when addressed/impact care, not only when actively treated. Option D is unsupported because eGFR 52 does not suggest stage 4.


NEW QUESTION # 59
Which diagnosis and treatment plan may generate a query?

  • A. Atrial fibrillation and amiodarone
  • B. Severe major depressive disorder and immunotherapy
  • C. Prostate carcinoma and luteinizing hormone-releasing hormone
  • D. Malnutrition and parenteral nutrition

Answer: B

Explanation:
Outpatient CDI queries are most commonly triggered when there is a disconnect between the documented diagnosis and the documented treatment plan, suggesting that the clinician may be managing an additional condition that is not clearly stated, or that the diagnosis is inaccurately documented. Options A and B reflect typical, clinically aligned management: luteinizing hormone-releasing hormone therapy is a standard treatment pathway for prostate carcinoma, and amiodarone is a recognized antiarrhythmic used in atrial fibrillation management in appropriate circumstances. Option C can also be clinically consistent because parenteral nutrition is often used when malnutrition is present and the patient cannot meet nutritional needs enterally. Option D is the outlier: "immunotherapy" is not a standard treatment for severe major depressive disorder and more commonly aligns with oncology or certain immune-mediated diseases. This mismatch would appropriately prompt a query to clarify the actual condition being treated (e.g., an active malignancy) or to confirm whether "immunotherapy" refers to something else (such as allergy immunotherapy) and whether depression is the correct, visit-relevant diagnosis being addressed.


NEW QUESTION # 60
Which of the following concepts BEST reflects how risk adjustment is related to cost efficiency metrics?

  • A. It is directly calculated from provider E&M levels.
  • B. It is applied to resource utilization measures.
  • C. It is related to physician time spent with patient.
  • D. It is supported by interventions and procedures.

Answer: B

Explanation:
Risk adjustment is used to make cost and efficiency comparisons fair by accounting for differences in patient severity and expected resource needs. In outpatient CDI, accurate documentation and coding of chronic and acute conditions (especially risk-adjusting diagnoses such as HCC-relevant conditions) directly influence the risk profile assigned to a patient population. That risk profile is then applied when evaluating utilization and cost measures-such as total cost of care, inpatient admissions, ED use, and other resource consumption-so that providers or groups caring for more complex patients are not inappropriately labeled as inefficient simply because their patients require more services. This aligns with option B: risk adjustment is applied to resource utilization measures. Option A is incorrect because E&M levels are a professional billing construct and are not the basis for risk score calculation. Option C is incorrect because physician time may affect E&M selection under certain rules, but it is not the mechanism for risk adjustment in cost efficiency analytics. Option D is incorrect because procedures/interventions describe services rendered, not the adjustment methodology itself.


NEW QUESTION # 61
Provider documentation states: "A 72-year-old patient with an active history of colon cancer, status post bowel resection, receiving chemotherapy. Newly diagnosed lung metastasis. Presents with UTI and elevated creatinine. Labs demonstrate a hemoglobin of 7.9, WBC of 2,500, and platelet count of 20,000." Which of the following is the query opportunity that supports a disease interaction that impacts the risk adjustment?

  • A. Colon cancer and chemotherapy
  • B. Colon cancer and lung metastasis
  • C. Acute tubular necrosis and UTI
  • D. Chemotherapy induced pancytopenia

Answer: D

Explanation:
In outpatient risk adjustment, "disease interactions" refer to model coefficients that are triggered when certain clinically related conditions co-exist, reflecting higher expected resource use than either condition alone. In this case, the record already supports active malignancy care (colon cancer on chemotherapy) with newly documented metastasis, and the lab pattern (anemia, leukopenia, and severe thrombocytopenia) strongly suggests pancytopenia. The highest-yield query opportunity is to clarify whether the cytopenias represent chemotherapy-induced pancytopenia (or another specified etiology) because a confirmed, well-specified hematologic complication in the context of active cancer treatment is the type of combination that commonly drives interaction effects in risk models (cancer plus significant systemic complication/manifestation). Options A and B describe clinical context but do not, by themselves, establish an interaction-ready, separately reportable complication. Option C is unrelated to the presented lab-driven severity signal. Querying and documenting chemotherapy-induced pancytopenia supports accurate capture of severity and the interaction impact.


NEW QUESTION # 62
A patient is seen in the obstetrical clinic, 6 weeks postpartum. She presents with resting heart rate of 58 BPM, initial blood pressure of 154/90, and respiratory rate of 20. She also complains of slight headaches, denies visual changes, and has no evidence of peripheral edema. History is significant for smoking and obesity. A blood pressure reading of 160/88 is taken at the end of the visit. The provider documents hypertension. Which of the following query opportunities is MOST appropriate?

  • A. Hypertensive crisis - unspecified
  • B. Whether the hypertension was pre-existing or developed during pregnancy
  • C. Association of hypertension to smoking
  • D. A more specific diagnosis, such as pre-eclampsia or eclampsia

Answer: B

Explanation:
In obstetric and postpartum coding, the most important clarification is the type/timing of hypertension because ICD-10-CM has distinct categories for chronic (pre-existing) hypertension, gestational hypertension, and hypertensive disorders that persist into or present during the postpartum period. At 6 weeks postpartum with elevated readings (including a systolic of 160) and headache, the documentation "hypertension" is not specific enough to determine whether this represents chronic hypertension that predates pregnancy, gestational hypertension that has not resolved, or another pregnancy-related hypertensive disorder requiring different obstetric coding and follow-up. ACDIS outpatient CDI guidance prioritizes queries that resolve coding-impactful ambiguity using clinically supported options without leading the provider. While postpartum preeclampsia could be a clinical consideration, the note does not provide key supporting elements (e.g., proteinuria or other definitive severe-feature criteria), so jumping directly to preeclampsia/eclampsia is less appropriate than clarifying onset and relationship to pregnancy. Linking hypertension to smoking is not a standard required linkage for diagnosis coding, and "hypertensive crisis" is not supported by the documentation provided.


NEW QUESTION # 63
The primary purpose of the RADV program is to

  • A. verify medical necessity of care provided.
  • B. ensure risk-adjusted payment integrity and accuracy.
  • C. identify over-payments rendered to individual physicians.
  • D. support accuracy of Evaluation and Management billing.

Answer: B

Explanation:
RADV (Risk Adjustment Data Validation) is a CMS audit program used in Medicare Advantage to confirm that diagnoses submitted for risk adjustment are supported by medical record documentation and meet reporting requirements. Its central aim is payment integrity-ensuring that risk-adjusted capitation payments to Medicare Advantage organizations are accurate based on valid, documented conditions. In outpatient CDI practice, RADV risk underscores why documentation must clearly support each reported diagnosis (e.g., condition evaluated/assessed/treated, clinically relevant, and properly documented by an eligible provider), because unsupported diagnoses can lead to payment recoupment and compliance exposure. RADV is not designed to assess medical necessity of the services provided (that is typically addressed through utilization review and other payer audits), nor is it focused on identifying overpayments to individual physicians (it targets plan-level risk adjustment payments). It also is separate from E/M leveling accuracy, which is governed by CPT/E/M guidelines and distinct audit processes. Therefore, the best definition of RADV's primary purpose is ensuring the integrity and accuracy of risk-adjusted payments.


NEW QUESTION # 64
Which of the following is the major difference between MIPS and APMs?

  • A. MIPS participation is required by eligible providers (non-participation results in a financial penalty), and APM participation is voluntary.
  • B. MIPS and APM participation is voluntary by eligible providers.
  • C. APM participation is required by eligible providers (non-participation results in a financial penalty), and MIPS participation is voluntary.
  • D. MIPS and APM participation is required of eligible providers.

Answer: A

Explanation:
MIPS (Merit-based Incentive Payment System) is the default Medicare Quality Payment Program pathway for most eligible clinicians who are not sufficiently participating in an Advanced APM. In practice, if a clinician is MIPS-eligible and does not meet reporting requirements (or performs poorly), Medicare applies a negative payment adjustment-so "non-participation" effectively carries financial risk. APMs (Alternative Payment Models), especially Advanced APMs, are not automatically required for all clinicians; they are model-based arrangements (often tied to specific payers, contracts, patient populations, and risk/quality terms) that clinicians typically enter through organizational participation decisions. A key operational difference emphasized in outpatient CDI education is that MIPS performance hinges on accurate, complete documentation supporting quality measures and resource use across a broad clinician population, whereas APM participation depends on being in a qualifying model and meeting its participation/threshold rules. Therefore, MIPS functions as the required/default track with potential penalties, while APM participation is elective and model-dependent.


NEW QUESTION # 65
For outpatient/provider services, the primary sources of coding authority include the ICD-10-CM Official Guidelines for Coding and Reporting, AHA's Coding Clinic for ICD-10-CM/PCS, as well as which of the following?

  • A. ICD-10-PCS Official Guidelines for Coding and Reporting and DRG Expert
  • B. AHA's Coding Clinic for HCPCS, ICD-10-PCS Official Guidelines for Coding and Reporting, and DRG Expert
  • C. AHA's Coding Clinic for HCPCS and ICD-10-PCS Official Guidelines for Coding and Reporting
  • D. AHA's Coding Clinic for HCPCS and AMA's CPT Assistant

Answer: D

Explanation:
Outpatient/provider coding relies on two major code sets: ICD-10-CM for diagnoses and CPT/HCPCS for professional services, procedures, and supplies. Because of that, outpatient coding authority is anchored not only in the ICD-10-CM Official Guidelines and AHA Coding Clinic guidance for diagnosis reporting, but also in the authoritative guidance that clarifies CPT/HCPCS reporting. ACDIS outpatient CDI education stresses that CDI specialists must understand both sides: the diagnosis coding rules (ICD-10-CM) and the procedural/service reporting rules (CPT/HCPCS) that drive much of outpatient reimbursement. AMA's CPT Assistant is a key interpretive authority for CPT coding guidance, while AHA's Coding Clinic for HCPCS provides clarification on HCPCS Level II reporting. The other options focus on ICD-10-PCS guidelines and DRG tools, which are primarily inpatient facility concepts (PCS is inpatient procedure coding; DRGs are inpatient payment groupers). Therefore, the correct supplemental outpatient authority pair is AHA's Coding Clinic for HCPCS and AMA's CPT Assistant.


NEW QUESTION # 66
After a CDI specialist describes how RAF is calculated, a provider states, "I just don't see how this impacts patient care." Which of the following is the MOST appropriate response related to the RAF score?

  • A. "It determines what you will be reimbursed."
  • B. "It predicts expected resources needed to care for the patient."
  • C. "It determines the patient's out of pocket expenses."
  • D. "It predicts medical necessity of ordered procedures/treatments."

Answer: B

Explanation:
RAF (Risk Adjustment Factor) is best explained to providers as a population-health and resource-planning tool, not a visit-level payment lever. In outpatient risk adjustment models, diagnoses and demographics are used to estimate the patient's overall disease burden and the expected cost/resources required to meet that patient's healthcare needs. When documentation accurately reflects active conditions and their specificity, the patient's risk profile is represented more realistically. That improves care in practical ways: it supports appropriate allocation of care management services (e.g., nurse navigators, chronic care programs), helps organizations anticipate medication, testing, specialist, and follow-up needs, and improves fairness of performance benchmarking by comparing outcomes and costs against similarly complex patients. Option A is overly simplistic because RAF does not directly determine an individual provider's reimbursement for a given encounter; it influences broader payment and benchmarking methodologies tied to attributed populations. Option C is not what RAF measures, and option D confuses RAF with medical necessity, which is based on clinical documentation and coverage rules, not a risk score.


NEW QUESTION # 67
Clinic visit documentation describes patient complaints of increased shortness of breath, following recent inpatient admission for pneumonia. Diagnoses include COPD - GOLD stage 3. Increase home O2 to 3 liters. Home health follow-up to begin home nebulizers, and Solu-Medrol ordered. Which of the following is the MOST significant query opportunity?

  • A. Specificity of the organism causing the pneumonia
  • B. Presence of chronic respiratory failure
  • C. Acuity of the COPD
  • D. Oxygen dependence

Answer: B

Explanation:
The documentation shows a patient with advanced COPD (GOLD stage 3) who now requires an increase in home oxygen to 3 liters, along with escalation of respiratory therapies (home nebulizers and systemic steroids). In outpatient CDI, an increased or ongoing home oxygen requirement is a strong clinical indicator that the provider may be managing chronic respiratory failure (or chronic hypoxemic respiratory failure), which is more clinically meaningful than simply documenting oxygen use as a status. "Oxygen dependence" is a status code and does not fully describe the underlying physiologic impairment driving the need for oxygen; chronic respiratory failure captures the severity and ongoing nature of the condition and better reflects risk, complexity, and medical necessity for durable oxygen therapy. Querying for pneumonia organism specificity is not as relevant in a follow-up visit unless pneumonia is still being actively treated and the organism is known. Querying COPD acuity (e.g., exacerbation) may be appropriate, but the most significant clarification prompted by increased home O2 is whether chronic respiratory failure is present and being managed.


NEW QUESTION # 68
Which of the following conditions or findings supports a diagnosis of diabetes?

  • A. Fasting glucose of 100
  • B. 2-hour blood sugar level of 90 during oral glucose tolerance test
  • C. Hypoglycemia
  • D. Hemoglobin A1c (HbA1c) level of 7.0%

Answer: D

Explanation:
In outpatient clinical documentation and chart review, diabetes can be supported by recognized diagnostic thresholds. An HbA1c value reflects average blood glucose over approximately the prior 2-3 months and is commonly used to diagnose and monitor diabetes. An HbA1c ≥ 6.5% (when confirmed per clinical practice standards and interpreted in the appropriate clinical context) supports a diagnosis of diabetes; therefore an HbA1c of 7.0% clearly meets the threshold and supports diabetes. By comparison, a 2-hour OGTT value of 90 mg/dL is normal and does not support diabetes (diabetes is typically supported when the 2-hour value is ≥ 200 mg/dL). Hypoglycemia is low blood glucose and is not diagnostic of diabetes; it may occur in diabetics due to treatment but can also occur in non-diabetics for many reasons. A fasting glucose of 100 mg/dL is at most borderline/prediabetes range and does not meet diagnostic criteria for diabetes (diabetes is supported at ≥ 126 mg/dL).


NEW QUESTION # 69
A patient with a PMH of DM, GERD, and HTN is seen in the clinic with complaints of stuffy nose, fever, and feeling tired for the past four days. The patient's medication list includes SSI, Prilosec, and Diovan. The provider documented: "Congestion, fever, malaise, DM, GERD, HTN. Continue OTC medications for congestion and fever. Rest. Return to the clinic in one week if symptoms persist." Which of the following ICD-10-CM guidelines BEST applies to how this scenario should be coded?

  • A. Selection of first-listed condition
  • B. Uncertain diagnoses
  • C. Encounters for general medical examination with abnormal finding
  • D. Codes that describe symptoms and signs

Answer: D

Explanation:
In the outpatient setting, when the provider does not document a definitive diagnosis for the acute complaint (e.g., influenza, sinusitis, URI), ICD-10-CM guidance directs coders to report the signs and symptoms that are documented and addressed. Here, the clinician documents congestion, fever, and malaise and provides treatment instructions for those symptoms (OTC meds, rest, follow-up). That makes the symptom codes the most appropriate representation of the reason for the encounter. Outpatient CDI principles further emphasize that chronic conditions like DM, GERD, and HTN should only be coded when the documentation shows they were evaluated, monitored, assessed/managed, or treated during the visit (e.g., status, control, medication adjustment, related testing, counseling). In this note, the plan targets only the acute symptoms and does not demonstrate active management of the chronic conditions beyond listing history/medications. Therefore, the guideline most directly applicable to correct coding of the encounter is codes that describe symptoms and signs.


NEW QUESTION # 70
In review of a clinic record, a CDI specialist notes the provider has directly copied and pasted a previous inpatient problem list into the current ambulatory visit note. Which of the following is the CDI specialist's BEST course of action?

  • A. Do not code conditions that were pasted from the problem list.
  • B. Assume the conditions are all relevant for this visit.
  • C. Educate the provider regarding the concerns with copying and pasting this list.
  • D. Query the provider for each of the conditions on the problem list.

Answer: C

Explanation:
Copy-and-paste of an inpatient problem list into an outpatient note creates significant documentation integrity risks: outdated diagnoses may be carried forward, resolved conditions may appear active, and the note may not clearly show which problems were actually evaluated or managed during the current encounter. Outpatient CDI best practice is not to assume relevance (eliminating D) and not to reflexively query every listed diagnosis (B), which can be burdensome, non-targeted, and may lead to "query fatigue." Likewise, blanket instruction to "not code" anything pasted (A) is not appropriate because some conditions may still be active and reportable if the provider documents assessment/management (e.g., monitoring, evaluation, addressing, or treatment). The most effective and sustainable action is provider education: explain why indiscriminate copy-forward threatens accuracy, compliance, medical necessity support, quality reporting, and risk adjustment validity; reinforce documenting current status and care provided for each active condition; and encourage updating the problem list and assessment to reflect what is truly addressed at the visit. Targeted queries can still be used when specific contradictions or high-impact ambiguities are identified.


NEW QUESTION # 71
A patient presents for a right inguinal herniorrhaphy in ambulatory surgery and is placed in observation status postoperatively. Provider documentation states: "Observation related to the post procedural urinary retention likely related to benign prostatic hyperplasia or adverse reaction to anesthesia." From this documentation, which of the following is the first-listed diagnosis?

  • A. Benign prostatic hyperplasia
  • B. Urinary retention
  • C. Right inguinal hernia
  • D. Adverse reaction to anesthetic

Answer: B

Explanation:
For outpatient/observation encounters, the first-listed diagnosis is the condition chiefly responsible for the services provided during that encounter. In this scenario, the patient's ambulatory surgery (herniorrhaphy) has already occurred, and the reason the patient is now in observation is explicitly documented as "post procedural urinary retention." That makes urinary retention the condition driving the extended monitoring, evaluation, and management in observation status. Benign prostatic hyperplasia and an adverse reaction to anesthesia are documented only as possible etiologies ("likely related to...or..."), and outpatient guidelines do not support coding uncertain diagnoses expressed as "likely" or as alternative possibilities without definitive confirmation. Therefore, those potential causes would not replace the confirmed problem that necessitated observation. The hernia was the reason for the procedure, but it is not the reason for the postoperative observation services described. Outpatient CDI practice reinforces documenting the clinical reason for observation and clearly distinguishing confirmed postoperative complications from suspected causes to support correct first-listed selection.


NEW QUESTION # 72
Which of the following is a form of a cardiac condition that may be treated with a beta-blocker?

  • A. Sinus bradycardia
  • B. Cardiomyopathy
  • C. Coronary artery disease
  • D. Third degree heart block

Answer: C

Explanation:
Beta-blockers are commonly used in the management of coronary artery disease (CAD) because they lower heart rate, decrease myocardial contractility, and reduce oxygen demand-key goals in treating stable angina and in secondary prevention after myocardial infarction. In outpatient chart review, ACDIS-focused clinical documentation education emphasizes linking the medication to the condition being managed (e.g., "CAD with angina-on metoprolol for symptom control" or "history of MI-on beta-blocker for secondary prevention") to support accurate diagnosis reporting and demonstrate ongoing assessment and treatment. By contrast, third-degree (complete) heart block and sinus bradycardia are conditions where beta-blockers are typically avoided or used only with extreme caution because they can worsen conduction delay and slow the heart rate further. Cardiomyopathy can sometimes be treated with certain evidence-based beta-blockers when the clinical context is systolic heart failure, but the option most broadly and reliably associated with beta-blocker treatment in standard outpatient practice and documentation is CAD.


NEW QUESTION # 73
A CDI specialist reviews the record of a patient with a history of CHF and DM Type 2 who was seen in the clinic earlier that day for possible bronchitis, fever, congestion, dyspnea, and cough. A chest x-ray indicated LLL infiltrate, and a nebulizer treatment was administered while in the office. Levofloxacin and albuterol were prescribed. Which of the following is MOST appropriate to query?

  • A. Acuity of bronchitis
  • B. Presence of pneumonia
  • C. Diabetic complications
  • D. Specificity of heart failure

Answer: B

Explanation:
The documented clinical picture and treatment plan better align with pneumonia than uncomplicated bronchitis, creating a clear documentation/coding consistency opportunity. A LLL infiltrate on chest x-ray is a classic clinical indicator for pneumonia, and prescribing levofloxacin supports treatment of a likely bacterial lower respiratory infection rather than routine viral bronchitis. The patient also has fever, dyspnea, cough, and required an in-office nebulizer treatment, all of which can accompany pneumonia and increase clinical significance. In outpatient CDI practice, the most appropriate query is the one that clarifies the provider's definitive diagnosis when objective findings and management suggest a more specific condition than what is stated (e.g., "possible bronchitis"). Querying for diabetic complications or heart failure specificity is not as directly supported by the encounter's indicators and treatment actions provided, and "acuity of bronchitis" is secondary if the true condition is pneumonia. Clarifying whether pneumonia is present ensures accurate reporting, medical necessity support, and appropriate risk/quality capture.


NEW QUESTION # 74
A patient with stage 3 CKD presents to the clinic for evaluation. Upon review of labs, an elevated iPTH and a normal phosphorus level are noted. Which of the following diagnoses may be appropriately queried based upon these lab values?

  • A. Hyperparathyroidism secondary to hypophosphatemia
  • B. CKD stage 3 with hypoparathyroidism
  • C. Secondary hyperparathyroidism of renal origin
  • D. Primary hyperparathyroidism

Answer: C

Explanation:
In stage 3 chronic kidney disease, impaired vitamin D activation and early disturbances in calcium-phosphate regulation commonly drive a compensatory rise in parathyroid hormone (PTH), known as secondary hyperparathyroidism of renal origin. Outpatient CDI chart review looks for clinical indicators that suggest a condition being evaluated or requiring management, and an elevated iPTH in a CKD patient is a classic indicator that supports querying the provider for CKD-related mineral and bone disorder, specifically renal secondary hyperparathyroidism, if it is clinically being assessed/treated (e.g., monitoring trends, prescribing vitamin D analogs, calcimimetics, dietary counseling, nephrology follow-up). Primary hyperparathyroidism is less supported here because it typically requires a different biochemical pattern and clinical context (often hypercalcemia) rather than being driven by CKD physiology. Hypoparathyroidism is the opposite process (low PTH), making option C inconsistent with the lab finding. Option D is not supported because phosphorus is normal, not low, and hypophosphatemia is not documented as a driver. Therefore, querying for renal secondary hyperparathyroidism is most appropriate.


NEW QUESTION # 75
A 62-year-old female with history of HTN, CAD, chronic cough and obesity is seen by her PCP. Which of the following treatment plans may result in a query?

  • A. Diagnostic chest x-ray
  • B. A visit with a nutrition specialist
  • C. Order placed for hemoglobin A1c (HbA1c)
  • D. Prescription written for the ACE inhibitor captopril

Answer: C

Explanation:
In outpatient CDI practice, a common reason to query is a mismatch between what is being evaluated/treated and what is explicitly documented as an active condition for the encounter. A diagnostic chest x-ray aligns with the already-documented symptom (chronic cough), and a nutrition specialist referral aligns with an established diagnosis (obesity); neither inherently suggests an undocumented condition. Prescribing captopril aligns with documented HTN management, so it generally would not create documentation ambiguity requiring clarification (even though ACE inhibitors can be associated with cough, the plan alone does not establish a new reportable diagnosis). In contrast, ordering an HbA1c often signals assessment for diabetes, impaired glucose regulation, or monitoring of known diabetes. Because diabetes is not listed in the history provided, the HbA1c order may prompt the CDI specialist to query whether the provider is evaluating a suspected or existing glycemic disorder, whether there is a diagnosis such as prediabetes/diabetes being addressed, and to ensure the record clearly supports the medical necessity and any reportable condition.


NEW QUESTION # 76
Provider documentation states: "Type 2 Diabetes with bilateral peripheral arteriosclerotic disease of LE. Bilateral pedal pulses present. Review Hgb A1C and CBC. No change in treatment. Hypertension evaluated and well controlled on Lopressor." Which of the following conditions should be coded?

  • A. Diabetes with peripheral angiopathy, hypertension
  • B. Diabetes with peripheral angiopathy, atherosclerosis bilateral legs, diabetes with circulatory complication, hypertension
  • C. Diabetes with peripheral angiopathy, atherosclerosis bilateral legs, hypertension
  • D. Diabetes without complications, atherosclerosis bilateral legs

Answer: C

Explanation:
The documentation explicitly links the conditions by stating "Type 2 Diabetes with bilateral peripheral arteriosclerotic disease of LE," which supports a diabetic circulatory manifestation rather than "diabetes without complications." In outpatient CDI chart review, the word "with" and clear provider linkage allow coding of diabetes "with peripheral angiopathy" (a diabetes complication category) when peripheral arterial/arteriosclerotic disease is documented as associated. In addition, best practice is to code both the diabetes complication category and the specific manifestation when supported, because the manifestation (atherosclerosis of the lower extremities, bilateral) further describes the clinical condition being evaluated. Hypertension is also evaluated and managed ("well controlled on Lopressor"), meeting outpatient reporting expectations for an active condition addressed during the encounter. Option D is incorrect because it double-counts the same concept-peripheral angiopathy already represents a circulatory complication, so adding a separate "diabetes with circulatory complication" statement is redundant rather than additive. Therefore, the correct coding set includes diabetes with peripheral angiopathy, the bilateral lower-extremity atherosclerosis manifestation, and hypertension.


NEW QUESTION # 77
CMS-HCC risk adjustment methodology seeks to measure

  • A. an individual's anticipated cost of care.
  • B. physician cost of care provision.
  • C. group beneficiary costs.
  • D. a beneficiary's risk of mortality.

Answer: A

Explanation:
The CMS-HCC risk adjustment methodology is designed to estimate an individual beneficiary's expected healthcare resource use and cost relative to an average Medicare beneficiary. It does this by converting demographic factors (such as age/sex and certain eligibility variables) plus documented, coded chronic conditions into a Risk Adjustment Factor (RAF). That RAF is then used to forecast the likely cost of caring for that specific patient in the payment year and to adjust benchmarks/payments so plans and providers managing sicker patients are compared more fairly to those managing healthier patients. This is why outpatient CDI emphasizes accurate, specific documentation and annual recapture of active conditions that are monitored, evaluated, assessed/addressed, or treated-because those coded conditions drive the predicted cost profile. CMS-HCC is not a mortality prediction tool (eliminating B), nor is it intended to measure "group costs" as the primary target (C), even though aggregated risk scores can be used for population analytics. It also does not measure an individual physician's cost of care provision (D); it measures patient-level expected cost burden.


NEW QUESTION # 78
Which of the following are appropriate clinical indicators to support a query related to alcohol dependency in remission?

  • A. The patient has history of cirrhosis of the liver and elevated liver enzymes.
  • B. The patient presents with nausea, vomiting, and distended abdomen.
  • C. The patient admits to occasional social drinking and recreational drug use.
  • D. The patient has history of excessive alcohol use and attends AA meetings.

Answer: D

Explanation:
To support a query for alcohol dependence in remission, outpatient CDI practice looks for indicators that reflect a documented history of dependence plus evidence the patient is actively maintaining sobriety or being followed for recovery status. Attendance at AA meetings together with a documented history of excessive alcohol use is a strong, direct indicator of recovery efforts and ongoing monitoring of a prior substance use disorder. This combination supports clarifying whether the provider intends to diagnose alcohol dependence in remission (versus current dependence, use without dependence, or no current disorder). By contrast, cirrhosis and elevated liver enzymes (option A) can be caused by many etiologies and do not, by themselves, establish dependence or remission status. Nausea, vomiting, and abdominal distention (option D) are nonspecific and may suggest acute illness or liver disease but are not specific to remission. Occasional social drinking with recreational drug use (option C) suggests current substance use and would not support "in remission" without additional documentation. Therefore, option B best supports a remission-related query.


NEW QUESTION # 79
A 76-year-old patient presents for a wellness visit. The patient's vitals are BP 120/80, T 98.7, R 19, and there are no abnormal findings in the exam. The patient has COPD, home oxygen, anemia, hypertension, diabetes, fatigue, and weakness. The patient's medications are called into the pharmacy and home health resource of choice. Which of the following is the BEST query option?

  • A. Acute blood loss anemia
  • B. Chronic respiratory failure
  • C. Peripheral neuropathy
  • D. CKD

Answer: B

Explanation:
The best query is chronic respiratory failure because home oxygen is a strong clinical indicator that often reflects an underlying chronic hypoxemic condition beyond uncomplicated COPD. Outpatient CDI guidance stresses that queries should be driven by present clinical indicators in the note and should seek clarification that impacts accurate diagnosis capture and ongoing care. Here, the provider documents COPD plus home oxygen and is arranging continued services (medication management and home health), which supports asking whether the patient has a reportable condition such as chronic respiratory failure with hypoxia (or COPD with chronic hypoxemia) and whether it is being monitored/managed. The other options lack support: acute blood loss anemia has no bleeding, hemodynamic instability, or acute findings; peripheral neuropathy is not assessed or described despite diabetes; and CKD has no labs, staging, history, or assessment. A compliant query would be non-leading and include the indicator (home O₂) and request the most accurate diagnosis and specificity/status.


NEW QUESTION # 80
Which performance metric is MOST appropriate for an outpatient program to share with providers?

  • A. APC payment rates
  • B. RAF scores
  • C. HCC per member per month payments
  • D. Major complication comorbidity (MCC) rates

Answer: B

Explanation:
Outpatient CDI programs should share provider-facing metrics that are clinically meaningful, aligned with ambulatory documentation goals, and unlikely to be perceived as payment-driven prompting. RAF scores are an appropriate metric because they reflect how well the documented and coded condition burden represents the patient panel's complexity in risk adjustment models. Discussing RAF supports education around accurate diagnosis capture, specificity, and annual recapture of active chronic conditions that are monitored, evaluated, assessed/addressed, or treated. In contrast, APC payment rates are facility OPPS payment constructs and typically are not actionable for individual ambulatory provider documentation improvement. HCC per member per month payments is explicitly financial and can create compliance risk by tying documentation discussions directly to payment, which outpatient CDI guidance warns against in provider messaging. MCC rates are primarily an inpatient DRG severity concept and are not the most relevant outpatient performance measure. Therefore, RAF scores best balance provider relevance, program goals, and compliant education focus.


NEW QUESTION # 81
Using the table above, which of the following HCC(s) should be assigned for documentation stating the patient has resolving AKI due to ATN, creatinine levels slowly returning to baseline, and CKD- stage 3-4?

  • A. HCC 327
  • B. HCC 328
  • C. HCC 329
  • D. HCC 326

Answer: A

Explanation:
In HCC risk adjustment, chronic kidney disease (CKD) is captured by stage-based HCCs that are hierarchical-only the highest supported CKD stage in the hierarchy is counted for RAF when multiple stages (or a range) are referenced. The documentation includes "CKD - stage 3-4," which indicates the patient's baseline CKD severity falls somewhere between stage 3 and stage 4. When selecting from the provided table, stage 4 maps to HCC 327 and is higher than stage 3 categories (HCC 328 for stage 3B and HCC 329 for stage 3 except 3B). AKI due to ATN describes an acute process and does not replace the need to capture baseline CKD stage when it is clinically relevant and documented. Outpatient CDI best practice would be to query the provider to specify the exact CKD stage (since "3-4" is imprecise), but when forced to choose from the hierarchy shown, the correct HCC assignment based on the highest stated stage in the documented range is HCC 327 (CKD stage 4).


NEW QUESTION # 82
......

Get 100% Real Free Clinical Documentation Specialist CCDS-O Sample Questions: https://actualtests.crampdf.com/CCDS-O-exam-prep-dumps.html